DIABETES RXD
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 01 Jun 2023)
What this means for you
Registered since 07 Nov 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86561027
- Registration number
- 5330094
- Mark type
- Stylized text
- Filed
- 11 Mar 2015
- Published for opposition
- 18 Aug 2015
- Registered
- 07 Nov 2017
- Attorney of record
- Eric P. Mirabel, JD, LLM
Goods and services
- Class 005 — Pharmaceuticals: Nutraceuticals for use as a dietary supplement in the management of diabetes risks and symptoms
Owner
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, CN
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, CN
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, CN
Prosecution history
- 01 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 May 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Nov 2022 — TEAS SECTION 8 & 15 RECEIVED
- 07 Nov 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Oct 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Sept 2017 — USE AMENDMENT FILED
- 18 Sept 2017 — TEAS STATEMENT OF USE RECEIVED
- 29 Mar 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2017 — SOU EXTENSION 3 GRANTED
- 27 Mar 2017 — SOU EXTENSION 3 FILED
- 27 Mar 2017 — SOU TEAS EXTENSION RECEIVED